Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Radiotherapy, Intensity-Modulated × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 29 Head and Neck Neoplasms 23 Prostatic Neoplasms 14 Oropharyngeal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Uterine Cervical Neoplasms 7 Gliosarcoma 7 Glioblastoma 7 Brain Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Squamous Cell 6 Lung Neoplasms 5 Tongue Neoplasms 4 Papillomavirus Infections 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Astrocytoma 4 Sarcoma 3 Glioma 3 Carcinoma 3 Urinary Bladder Neoplasms 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neuroblastoma 2 Neoplasms 2 Mesothelioma, Malignant 2 Leukemia 2

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡